Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
11,689,865
-
Share change
-
+2,486,126
-
Total reported value
-
$489,456,000
-
Price per share
-
$41.89
-
Number of holders
-
68
-
Value change
-
+$142,381,244
-
Number of buys
-
58
-
Number of sells
-
13
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q1 2015
As of 31 Mar 2015,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,689,865 shares.
The largest 10 holders included
ProQuest Associates IV LLC, JANUS CAPITAL MANAGEMENT LLC, Consonance Capital Management LP, JW Asset Management, LLC, GENERAL ELECTRIC CO, Cormorant Asset Management, LLC, Park West Asset Management LLC, Allianz Asset Management AG, VANGUARD GROUP INC, and MORGAN STANLEY.
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.